Enrollment of DAPA-treated CKD patients without DM
proteinuria, CKD, diabetes
DIABETES
A total of 126 patients treated with DAPA 10 mg daily between September 2021 and March 2022 was registered. Fifty-two participants did not have eGFR data before the DAPA initiation and 12 participants did not have four-point proteinuria data (1 month and just before the DAPA initiation and 1 month and 2 months after the DAPA initiation). Based on the medical record of Kurume University hospital, 11 patients were diagnosed of diabetes or treated with anti-diabetes agents. Thus, a total of 75 patients was excluded from the present study, and the remaining 51 CKD patients without DM were enrolled (Fig. (